CBZ-D-高苯丙氨酸 | 138812-70-1

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 苯丙氨酸类衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: CBZ-D-高苯丙氨酸
• 英文名称: Cbz-D-Homophe
• 英文别名: Cbz-D-homoPhe-OH；Z-D-Hph-OH；(R)-2-benzyloxycarbonylamino-4-phenyl-butyric acid；(R)-2-Benzyloxycarbonylamino-4-phenyl-buttersaeure；N-(benzyloxycarbonyl)D-homophenylalanine；CBZ-D-homophenylalanine；(R)-2-(((Benzyloxy)carbonyl)amino)-4-phenylbutanoic acid；(2R)-4-phenyl-2-(phenylmethoxycarbonylamino)butanoic acid
• CAS: 138812-70-1
• 化学式: C₁₈H₁₉NO₄
• 分子量: 313.353
• InChiKey: GUWSQYJXSRIJCI-MRXNPFEDSA-N

物化性质

• 沸点：
  521.2±50.0 °C(Predicted)
• 密度：
  1.222±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  23
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  75.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2924299090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Z-D-Homophe-oh
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Z-D-Homophe-oh
CAS number: 138812-70-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C18H19NO4
Molecular weight: 313.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  CBZ-D-高苯丙氨酸 在 三乙胺 、 N,N'-二环己基碳二亚胺 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 10.5h， 生成 (R)-2-((R)-2-Benzyloxycarbonylamino-4-phenyl-butyrylamino)-3-methyl-butyric acid 2,5-dioxo-pyrrolidin-1-yl ester
  参考文献：
  名称：

  在寻找新的抗癌药。XXIV：含有2-氯乙基-和[N'-（2-氯乙基）-N'-亚硝基]-氨基羰基的氨基酸和二肽的合成和抗癌活性。

  摘要：

  一系列L，L-（42、44、46和60）和D，D-（43、45、47和61）二肽衍生物，由苯甘氨酸，苯丙氨酸，高苯丙氨酸和缬氨酸组成，并含有2-氯乙基氨基制备C末端的N'-基团和二肽N末端的N'-（2-氯乙基）-N'-亚硝基-氨基羰基。首先在体内评估二肽衍生物（42-47、60和61）对鼠淋巴细胞性白血病P388的抗癌活性。化合物42、44、46和60的活性在寿命上增加了46％至111％（％ILS），而化合物43的活性很小（％ILS = 31），而45、47和61则没有活性。通常，L，L系列表现出低至良好的活性（％ILS = 46-111），而相应的D，D系列（除43（％ILS = 31）之外）没有活性。L-丙氨酸（74），L-苯丙氨酸（75）和L-天冬氨酸（76）的结构相似的单氨基酸衍生物对P388的活性高于二肽衍生物（即481％，297％和481％ILS，分别）。然后在体内针对鼠淋巴白

  DOI：

  10.1002/jps.2600820102
• 作为产物：
  描述：

  benzyl (4R)-2,2-dimethyl-4-vinyl-1,3-oxazolidine-3-carboxylate 在 9-borabicyclo[3.3.1]nonane dimer 、 jones reagent 作用下， 以 四氢呋喃 、 丙酮 为溶剂， 反应 6.0h， 生成 CBZ-D-高苯丙氨酸
  参考文献：
  名称：

  通过硼氢化-铃木交叉偶联对映体纯的α-氨基酸合成。

  摘要：

  Garner醛衍生的亚甲基烯烃5和相应的苄氧羰基化合物25与9-BBN-H进行氢硼化，然后与芳基和乙烯基卤化物进行钯催化的Suzuki偶联反应。一锅水解氧化后，分离出一系列已知和新颖的非蛋白氨基酸作为其N保护的衍生物。这些新颖的有机硼烷高丙氨酸阴离子当量是在温和条件下产生的，并且具有宽泛的官能团耐受性：富电子和贫芳香族碘化物和溴化物（以及乙烯基溴化物）都经过有效的Suzuki偶联。还介绍了此方法的扩展，以制备介孔DAP，R，R-DAP和R，R-DAS。

  DOI：

  10.1021/jo010865a

文献信息

• An Efficient Approach to Chiral C8/C9-Piperazino-Substituted 1,4-Benzodiazepin-2-ones as Peptidomimetic Scaffolds
  作者：Stefania Butini、Emanuele Gabellieri、Paul Brady Huleatt、Giuseppe Campiani、Silvia Franceschini、Margherita Brindisi、Sindu Ros、Salvatore Sanna Coccone、Isabella Fiorini、Ettore Novellino、Gianluca Giorgi、Sandra Gemma

  DOI：10.1021/jo8015456

  日期：2008.11.7

  a versatile approach to introduce cyclic, protonatable functionality at C8/C9. Introduction of the piperazine system at C8 and C9 gave access to a unique functionalization of the versatile benzodiazepine skeleton, broadening tailoring options on the benzofused side of the molecule, and the possibility of discovering novel peptidomimetics potentially able to modulate protein-protein interactions. Coupling

  干扰生物过程的一种有前途的方法是通过充当拟肽的小分子调节蛋白质-蛋白质相互作用。1,4-苯并二氮杂pine骨架已被广泛报道为模仿肽的致药系统。尽管已经公开了几种通往C6-8取代的苯并二氮杂卓的合成途径，但几乎没有报道在C9处被取代的1，4-苯并二氮杂卓。在这里，我们描述了一种通用的方法，可以在C8 / C9处引入循环的，可质子化的功能。在C8和C9引入哌嗪系统后，即可获得通用的苯并二氮杂skeleton骨架的独特功能化，拓宽了分子在苯并稠合侧的剪裁选择，并发现了可能调节蛋白质-蛋白质相互作用的新型肽模拟物。在温和条件下，将活化的氨基酸与反应性较弱的苯胺偶联，同时避免了外消旋作用，可轻松获得这些化合物。通过使用三苯基膦和六氯丙酮，在低温和无酸/碱的条件下利用酰氯的快速形成，可以实现有效的氨基酸活化。该方法成功地导致了高反应产率，没有产生外消旋作用（ee> 98％，如通过使用手性溶剂化剂所证明
• An efficient and enantioselective synthesis of a chiral primary amine
  作者：Youngchan Son、Chihyo Park、Jong Sung Koh、Nakyen Choy、Chang S. Lee、Ho-il Choi、Sung Chun Kim、Heungsik Yoon

  DOI：10.1016/s0040-4039(00)73087-5

  日期：1994.5

  An efficient and enantioselective method for the preparation of a chiral primary amine has been developed. Starting from N-protected L or D-amino acid the sequence involves coupling with N-methoxy-N-methylamine, acylation, olefination with potassium bis(trimethylsilyl)amide, and hydrogenation.

  已经开发了制备手性伯胺的有效和对映选择性的方法。从N-保护的L或D-氨基酸开始，该序列包括与N-甲氧基-N-甲胺偶联，酰化，与双（三甲基甲硅烷基）酰胺钾的烯化以及氢化。
• Compounds and Compositions as Channel Activating Protease Inhibitors
  申请人：Tully C. David

  公开号：US20070275906A1

  公开（公告）日：2007-11-29

  The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating channel activating proteases, and methods for, using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, including but not limited to prostasin, PRSS22, TMPRSS11 (e.g., TMPRSS11B, TMPRSS11E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptase (MTSP-1), CAP2, CAP3, trypsin, cathepsin A, or neutrophil elastase.

  该发明提供了化合物及其制药组合物，用于调节通道激活蛋白酶，并使用这些化合物来治疗、改善或预防与通道激活蛋白酶相关的疾病的方法，包括但不限于前列腺蛋白酶、PRSS22、TMPRSS11（例如TMPRSS11B、TMPRSS11E）、TMPRSS2、TMPRSS3、TMPRSS4（MTSP-2）、麦曲蛋白酶（MTSP-1）、CAP2、CAP3、胰蛋白酶、卡特普辛A或中性粒细胞弹性蛋白酶。
• Synthesis of rapamycin-peptide hybrid molecule (RAP-P): High affinity FKBP12 ligand
  作者：Tushar K. Chakraborty、Khaja Azhar Hussain

  DOI：10.1016/s0040-4020(96)00068-3

  日期：1996.3

  The syntheses of two rapamycin-peptide hybrid molecules RAP-P (5 and 6) containing the rapamycin-FK 506-ascomycin binding domain and different peptide tethers are described in detail.

  详细描述了两个包含雷帕霉素-FK 506-子囊霉素结合域和不同肽系链的雷帕霉素-肽杂合分子RAP-P（5和6）的合成。
• [EN] EFFLUX PUMP INHIBITORS<br/>[FR] INHIBITEURS DE POMPE D'ECOULEMENT
  申请人：MICROCIDE PHARMACEUTICALS, INC.

  公开号：WO1999037667A1

  公开（公告）日：1999-07-29

  (EN) Compounds are described which have efflux pump inhibitor activity. Also described are methods of using such efflux pump inhibitor compounds and pharmaceutical compositions which include such compounds.(FR) L'invention concerne des composés présentant une activité d'inhibiteur de pompe d'écoulement. L'invention concerne également des méthodes d'utilisation de ces composés inhibiteurs et des compositions pharmaceutiques renfermant de tels composés.

  （中文翻译）描述了具有外排泵抑制剂活性的化合物。还描述了使用这种外排泵抑制剂化合物的方法和包括这种化合物的药物组合物。